Myriad Genetics (MYGN) P/E (2009 - 2026)
Myriad Genetics (MYGN) P/E from Sep 30, 2009 to Jul 21, 2026. The TTM Myriad Genetics (MYGN) P/E is -1.38. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Myriad Genetics (MYGN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.38 | -11.97% |
| 2025 | -1.56 | -84.03% |
| 2024 | -9.80 | +71.80% |
| 2023 | -5.70 | -62.31% |
| 2022 | -15.13 | -80.17% |
| 2021 | -76.28 | +103.88% |
| 2020 | -37.42 | -51.71% |
| 2019 | -77.48 | +265.23% |
| 2018 | -21.22 | -189.22% |
| 2017 | 23.78 | +72.90% |
| 2016 | 13.75 | -51.32% |
| 2015 | 28.25 | +24.89% |
| 2014 | 22.62 | +161.55% |
| 2013 | 8.65 | -52.24% |
| 2012 | 18.11 | +3.18% |
| 2011 | 17.55 | +10.24% |
| 2010 | 15.92 | -57.04% |
| 2009 | 37.07 | N/A |
Comparison Myriad Genetics (MYGN) P/E with competitors
Myriad Genetics (MYGN) P/E is -1.38.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -176.11% |
| MBAI | CheckCap Ltd | 1.71 | -224.32% |
| FONR | Fonar Corp | 15.48 | -1223.53% |
| QGEN | Qiagen NV | 20.03 | -1553.92% |
| DGX | Quest Diagnostics Inc | 22.47 | -1731.29% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -1832.75% |
| IQV | IQVIA Holdings Inc | 25.28 | -1935.23% |
| A | Agilent Technologies Inc | 26.96 | -2056.83% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -2388.62% |
| MTD | Mettler-Toledo International Inc | 32.45 | -2455.51% |
| MEDP | Medpace Holdings Inc | 32.55 | -2462.73% |
| DHR | Danaher Corp | 38.55 | -2898.51% |
| IDXX | Idexx Laboratories Inc | 40.58 | -3045.27% |
| ILMN | Illumina Inc | 44.12 | -3302.55% |
| RVTY | Revvity Inc | 52.68 | -3924.00% |
| VCYT | Veracyte Inc | 53.71 | -3998.82% |
| ICLR | Icon Plc | 57.45 | -4270.26% |
| SHC | Sotera Health Company | 74.08 | -5477.62% |
| WAT | Waters Corp | 102.79 | -7561.01% |